Patent · US Active

85kDa neisserial antigen

US7700119B2 · kind B2 · utility

3Cited by

1References

3Claims

0Family size

Assignee

Novartis Vaccines and Diagnostics, Inc. · US

Inventors

Marzia Monica Giuliani · Siena, IT
Mariagrazia Pizza · Siena, IT
Rino Rappuoli · Siena, IT
Johan Holst · Oslo, NO

Key dates

Filing date	Nov 1, 2005
Grant date	Apr 20, 2010
Priority date	—
Expiry date	Mar 19, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An 85 kDa antigen from Neisseria meningitidis and Neisseria gonorrhoeae has been cloned, sequenced and expressed. The antigen is common to diverse strains, serogroups and serotypes of N. meningitidis, and also to N. gonorrhoeae, N. polysaccharia and N. lactamica. The protein sequences of N. meningitidis (serogroups A and B) and N. gonorrhoeae are highly homologous.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.